Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plasma Metabolites Associate with All-Cause Mortality in Individuals with Type 2 Diabetes
Filip Ottosson, Einar Smith, Céline Fernandez, et al.
Metabolites (2020) Vol. 10, Iss. 8, pp. 315-315
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Bilirubin Levels Are Negatively Correlated with Adiposity in Obese Men and Women, and Its Catabolized Product, Urobilin, Is Positively Associated with Insulin Resistance
Zachary A. Kipp, Mei Xu, Evelyn A. Bates, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 170-170
Open Access | Times Cited: 28
Metabolomic Markers of Ultra-Processed Food and Incident CKD
Donghan Su, Jingsha Chen, Shutong Du, et al.
Clinical Journal of the American Society of Nephrology (2023) Vol. 18, Iss. 3, pp. 327-336
Open Access | Times Cited: 26
Heme oxygenase, biliverdin reductase, and bilirubin pathways regulate oxidative stress and insulin resistance: a focus on diabetes and therapeutics
Wang‐Hsin Lee, Zachary A. Kipp, Sally Pauss, et al.
Clinical Science (2025) Vol. 139, Iss. 02, pp. 171-198
Open Access | Times Cited: 1
A multi-metabolite signature robustly predicts long-term mortality in the PREDIMED trial and several US cohorts
Gonzalo Fernández-Duval, Cristina Razquín, Fenglei Wang, et al.
Metabolism (2025), pp. 156195-156195
Closed Access | Times Cited: 1
Association of circulating branched-chain amino acids with risk of cardiovascular disease: A systematic review and meta-analysis
Yaqin Wang, Keyong Huang, Fangchao Liu, et al.
Atherosclerosis (2022) Vol. 350, pp. 90-96
Closed Access | Times Cited: 23
Plasma Metabolome Predicts Aortic Stiffness and Future Risk of Coronary Artery Disease and Mortality After 23 Years of Follow‐Up in the General Population
Filip Ottosson, Gunnar Engström, Marju Orho‐Melander, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 9
Open Access | Times Cited: 5
Circulating Metabolites Associate With and Improve the Prediction of All-Cause Mortality in Type 2 Diabetes
Maria Giovanna Scarale, Mario Mastroianno, Cornelia Prehn, et al.
Diabetes (2022) Vol. 71, Iss. 6, pp. 1363-1370
Open Access | Times Cited: 20
Duality of Branched-Chain Amino Acids in Chronic Cardiovascular Disease: Potential Biomarkers versus Active Pathophysiological Promoters
Daniela Maria Tănase, Emilia Valasciuc, Claudia Florida Costea, et al.
Nutrients (2024) Vol. 16, Iss. 12, pp. 1972-1972
Open Access | Times Cited: 4
Bilirubin bioconversion to urobilin in the gut-liver-kidney axis: A biomarker for insulin resistance in the Cardiovascular-Kidney-Metabolic (CKM) Syndrome
Zachary A. Kipp, Olufunto O. Badmus, David E. Stec, et al.
Metabolism (2024), pp. 156081-156081
Open Access | Times Cited: 4
Gut microbiota and bilirubin metabolism: unveiling new pathways in health and disease
Libor Vı́tek, Claudio Tiribelli
Trends in Molecular Medicine (2025)
Closed Access
Urobilin Derived from Bilirubin Bioconversion Binds Albumin and May Interfere with Bilirubin Interacting with Albumin: Implications for Disease Pathology
K. Williams, Priyanka Suryadevara, Chang‐Guo Zhan, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 302-302
Open Access
A synthesis and quantification method for endogenous metabolites dimethylguanidino valeric acid
Yueyuan Han, Jiahui Wang, Qianling Xiong, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Plasma metabolomics provides new insights into the relationship between metabolites and outcomes and left ventricular remodeling of coronary artery disease
Qian Zhu, Min Qin, Zixian Wang, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Phenylacetylglutamine as a novel biomarker of type 2 diabetes with distal symmetric polyneuropathy by metabolomics
Jiatuo Xu, Ming Cai, Z. Wang, et al.
Journal of Endocrinological Investigation (2022) Vol. 46, Iss. 5, pp. 869-882
Open Access | Times Cited: 18
Metabolomics of Type 1 and Type 2 Diabetes: Insights into Risk Prediction and Mechanisms
Daniel Gonzalez Izundegui, Matthew Nayor
Current Diabetes Reports (2022) Vol. 22, Iss. 2, pp. 65-76
Open Access | Times Cited: 17
The emergent role of mitochondrial RNA modifications in metabolic alterations
Hatim Boughanem, Yvonne Böttcher, João Tomé‐Carneiro, et al.
Wiley Interdisciplinary Reviews - RNA (2022) Vol. 14, Iss. 2
Open Access | Times Cited: 16
Recent advances in cardiovascular disease research driven by metabolomics technologies in the context of systems biology
Boyao Zhang, Thierry Schmidlin
npj Metabolic Health and Disease (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 3
The association between plasma metabolites and future risk of all‐cause mortality
Yingxiao Yan, Einar Smith, Olle Melander, et al.
Journal of Internal Medicine (2022) Vol. 292, Iss. 5, pp. 804-815
Open Access | Times Cited: 14
Association of Plasma Metabolomic Biomarkers With Persistent Tinnitus
Oana A. Zeleznik, D. Bradley Welling, Konstantina M. Stanković, et al.
JAMA Otolaryngology–Head & Neck Surgery (2023) Vol. 149, Iss. 5, pp. 404-404
Closed Access | Times Cited: 7
The Kynurenine Pathway in Obese Middle-Aged Women with Normoglycemia and Type 2 Diabetes
Justyna Kubacka, Magdalena Staniszewska, Ilona Sadok, et al.
Metabolites (2022) Vol. 12, Iss. 6, pp. 492-492
Open Access | Times Cited: 12
Metabolomics in atrial fibrillation - A review and meta-analysis of blood, tissue and animal models
Leonoor F.J. Wijdeveld, Amelie C. T. Collinet, Fabries G. Huiskes, et al.
Journal of Molecular and Cellular Cardiology (2024)
Open Access | Times Cited: 2
Metabolite signatures of chronological age, aging, survival, and longevity
Paola Sebastiani, Stefano Monti, Michael S. Lustgarten, et al.
Cell Reports (2024) Vol. 43, Iss. 11, pp. 114913-114913
Closed Access | Times Cited: 2
Application of Metabolomics and Traditional Chinese Medicine for Type 2 Diabetes Mellitus Treatment
Jing Li, Na Zhu, Yaqiong Wang, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 4269-4282
Open Access | Times Cited: 5
Metabolomics signature of cardiovascular disease in patients with diabetes, a narrative review
Salimeh Dodangeh, Hananeh Taghizadeh, Shaghayegh Hosseinkhani, et al.
Journal of Diabetes & Metabolic Disorders (2023) Vol. 22, Iss. 2, pp. 985-994
Open Access | Times Cited: 4
Physical performance and plasma metabolic profile as potential prognostic factors in metastatic lung cancer patients
Willian das Neves, Christiano R. R. Alves, Gabriela dos Santos, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 11
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top